SCHEMBL13197239

SCHEMBL13197239

CC(C)C(=O)c1cccc(C(=O)C(C)C)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.52
TDP1 Q9NUW8 2/20 0.52
ALOX15 P16050 1/20 0.52
TSHR P16473 1/20 0.52
ACMSD Q8TDX5 1/20 0.52
CYP1A2 P05177 1/20 0.45
GAA P10253 3/20 0.42
RECQL P46063 2/20 0.42
DBH P09172 1/20 0.42
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 1/20 0.41
MAPT P10636 2/20 0.40
P2RX7 Q99572 1/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
HTT P42858 1/20 0.38
NPC1 O15118 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8022716 0.87 KDM4E (0.41) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL2605492 0.87 P2RX7 (0.55) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL12553244 0.86 KDM4E (0.39) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL17833743 0.86 XIAP (0.47) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL2622480 0.86 GRM4 (0.42) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL23879790 0.82 BRD4 (0.44) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL9927086 0.82 PGK1 (0.38) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL21911852 0.82 TERT (0.49) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL13044079 0.82 CBLB (0.40) KDM4ETDP1ALOX15TSHRACMSD
SCHEMBL12704648 0.82 KDM4E (0.48) KDM4ETDP1ALOX15TSHRACMSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100203012-A1 IAP BIR DOMAIN BINDING COMPOUNDS AEGERA THERAPEUTICS, INC. (CA) 2010-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100203012-A1 IAP BIR DOMAIN BINDING COMPOUNDS BIRC5, BIRC2, BIRC3 KDM4E 4223/4885TDP1 842/4885ALOX15 4587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.